Andrew M. Lipczynski

Pfizer (United Kingdom)

Papers

1

Total Citations

36

H-Index

1

About

Andrew M. Lipczynski is a distinguished analytical chemist whose work centers on method development for detecting trace-level genotoxic impurities, particularly in pharmaceutical and food safety contexts. His most cited paper, "Development and validation of an automated static headspace gas chromatography–mass spectrometry (SHS-GC–MS) method for monitoring the formation of ethyl methane sulfonate from ethanol and methane sulfonic acid" (2008, 36 citations), exemplifies his expertise in combining automation with sensitive detection techniques. This work provided a robust, validated approach to quantifying a potentially carcinogenic impurity formed during drug manufacturing, addressing a critical regulatory and safety concern. Lipczynski’s contributions have advanced the reliability of impurity profiling, enabling more precise risk assessments in complex matrices. His research bridges fundamental analytical chemistry and applied industrial quality control, with his SHS-GC–MS method serving as a benchmark for similar studies. While his citation count reflects a focused but impactful niche, his methodological rigor and practical relevance have made his work a reference point for scientists tackling genotoxic impurity analysis. Lipczynski’s achievements underscore the importance of meticulous validation in safeguarding public health through analytical innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of an automated static headspace gas chromatography–mass spectrometry (SHS-GC–MS) method for monitoring the formation of ethyl methane sulfonate from ethanol and methane sulfonic acid
36 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Pfizer (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago